Objectives We performed a systematic review and network meta-analysis of randomized
controlled trials (RCTs) to provide updated information regarding the clinical efficacy of …

Purpose This review was aimed to synthesise the best available evidence on the
effectiveness and safety of remdesivir in the treatment of moderate to severe COVID-19 …

Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-
hospital all-cause mortality in a lar Page 1 © The Author(s) 2021. Published by Oxford University …

Background Remdesivir (RDV) improved clinical outcomes among hospitalized patients with
coronavirus disease 2019 (COVID-19) in randomized trials, but data from clinical practice …

Exacerbated and persistent innate immune response marked by pro-inflammatory cytokine
expression is thought to be a major driver of chronic COVID-19 pathology. Although …

Background Remdesivir is considered to be a specific drug for treating coronavirus disease
2019. This systematic review aims to evaluate the clinical efficacy and risk of remdesivir …

Background In order for healthcare systems to prepare for future waves of COVID-19, an in-
depth understanding of clinical predictors is essential for efficient triage of hospitalized …

Background Remdesivir is widely used for the treatment of coronavirus disease 2019
(COVID-19), but controversies regarding its efficacy still remain. Methods A retrospective …

Due to the lack of an etiologic treatment for SARS-CoV-2 and the difficulties involved in
developing new drugs, some drugs already approved for other diseases or with efficacy …

Objective: Studies in the literature regarding the use of remdesivir to treat COVID-19 patients
have shown conflicting results. This study sought to answer questions related to the use of …